Manali S. Phadke

Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage

Natalia F. Krynetskaia, Manali S. Phadke, Sachin Jadhav et al. · Molecular Cancer Therapeutics · 2009 · 77 citations · Full text

Medicine, Molecular Biology, Oncology +16

Glyceraldehyde 3-Phosphate Dehydrogenase Depletion Induces Cell Cycle Arrest and Resistance to Antimetabolites in Human Carcinoma Cell Lines

Manali S. Phadke, Natalia F. Krynetskaia, Anurag Mishra et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 52 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Manali S. Phadke, Zhihua Chen, Jiannong Li et al. · Cancer Immunology Research · 2021 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression

Manali S. Phadke, Patrizia Sini, Keiran S.M. Smalley · Molecular Cancer Therapeutics · 2015 · 42 citations · Full text

Medicine, Oncology, Pharmacology +15

Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models

Manali S. Phadke, Jiannong Li, Zhihua Chen et al. · Journal for ImmunoTherapy of Cancer · 2023 · 13 citations · Full text

Medicine, Immunology, Oncology +17